Flavin-containing monooxygenase activity can be inhibited by nitric oxide-mediated S-nitrosylation

Life Sciences

Volumn 75, Issue 21, 2004, Pages 2559-2572

  Ryu, Seung Duk ^a   Yi, Hyeon Gyu ^a   Cha, Young Nam ^a   Kang, Ju Hee ^a   Kang, Ju Seup ^b   Jeon, Yong Cheol ^c   Park, Hwon Kyum ^c   Yu, Tae Moo ^d   Lee, Jung Nam ^a   Park, Chang Shin ^a  

^a Inha University School of Medicine   (South Korea)

^b University of Seoul   (South Korea)

^c Kyungki do South Korea   (South Korea)

^d Korea Food and Drug Administration   (South Korea)

Author keywords

Ascorbate; Dithiothreitol; Flavin containing monooxygenase; Nitric oxide; S nitrosylation

Indexed keywords

ASCORBIC ACID; DIETHYLAMINE; DIMETHYLANILINE MONOOXYGENASE; DITHIOTHREITOL; LINSIDOMINE; LIVER ENZYME; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; RANITIDINE; THIOBENZAMIDE; TRIMETHYLAMINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME MODIFICATION; ENZYME SUBUNIT; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; NITROSYLATION; OXIDATION; PROTEIN EXPRESSION;

ADULT; ASCORBIC ACID; CARCINOMA, HEPATOCELLULAR; DITHIOTHREITOL; ENZYME INHIBITORS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; METHYLAMINES; MICROSOMES, LIVER; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSATION; OXYGENASES; RANITIDINE; RECOMBINANT PROTEINS; THIOAMIDES;

EID: 4444246534     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.05.018     Document Type: Article

References (38)

1. T. Akaike, and H. Maeda Nitric oxide and virus infection Immunology 101 3 2000 300 308
2. P.M. Bauer, J.M. Fukuto, G.M. Buga, A.E. Pegg, and L.J. Ignarro Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation Biochemical and Biophysical Research Communications 262 2 1999 355 358
3. J.R. Cashman Structural and catalytic properties of the mammalian flavin-containing monooxygenase Chemical Research in Toxicology 8 2 1995 166 181
4. J.R. Cashman The role of flavin-containing monooxygenases in drug metabolism and development Current Opinion in Drug Discovery & Development 6 4 2003 486 493
5. J.R. Cashman, S.B. Park, C.E. Berkman, and L.E. Cashman Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humans Chemico-Biological Interactions 96 1 1995 33 46
6. W.G. Chung, and D.R. Buhler The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs Toxicology and Applied Pharmacology 127 2 1994 314 319
7. P.Y. Cheng, and E.T. Morgan Hepatic cytochrome P450 regulation in disease states Current Drug Metabolism 2 2 2001 165 183
8. W.G. Chung, C.S. Park, H.K. Roh, W.K. Lee, and Y.N. Cha Oxidation of ranitidine by isozymes of flavin-containing monooxygenase and cytochrome P450 Japanese Journal of Pharmacology 84 2 2000 213 220
9. D.A. Geller, M. Di Silvio, A.K. Nussler, S.C. Wang, R.A. Shapiro, R.L. Simmons, and T.R. Billiar Nitric oxide synthase expression is induced in hepatocytes in vivo during hepatic inflammation Journal of Surgical Research 55 4 1993 427 432
10. 15]nitrate in biological fluids Analytical Biochemistry 126 1 1982 131 138
11. H. Hara, and T. Adachi Contribution of hepatocyte nuclear factor-4 to down-regulation of CYP2D6 gene expression by nitric oxide Molecular Pharmacology 61 1 2002 194 200
12. K. Itoh, T. Kimura, T. Yokoi, S. Itoh, and T. Kamataki Rat liver flavin-containing monooxygenase (FMO): cDNA cloning and expression in yeast Biochimica et Biophysica Acta 1173 2 1993 165 171
13. Y. Ji, V. Toader, and B.M. Bennett Regulation of microsomal and cytosolic glutathione S-transferase activities by S-nitrosylation Biochemical Pharmacology 63 8 2002 1397 1404
14. J.H. Kang, W.G. Chung, K.H. Lee, C.S. Park, J.S. Kang, I.C. Shin, H.K. Roh, M.S. Dong, H.M. Baek, and Y.N. Cha Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FM03 gene mutations in a Korean population Pharmacogenetics 10 1 2000 67 78
15. O.G. Khatsenko, S.S. Gross, A.B. Rifkind, and J.R. Vane Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants Proceedings of the National Academy of Sciences of the United States of America 90 23 1993 11147 11151
16. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent Journal of Biological Chemistry 193 1 1951 265 275
17. J. Li, T.R. Billiar, R.V. Talanian, and Y.M. Kim Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation Biochemical and Biophysical Research Communications 240 2 1997 419 424
18. P.L. Majano, C. Garcia-Monzon, M. Lopez-Cabrera, E. Lara-Pezzi, E. Fernandez-Ruiz, C. Garcia-Iglesias, M.J. Borque, and R. Moreno-Otero Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation Journal of Clinical Investigation 101 7 1998 1343 1352
19. Y. Minamiyama, S. Takemura, S. Imaoka, Y. Funae, Y. Tanimoto, and M. Inoue Irreversible inhibition of cytochrome P450 by nitric oxide Journal of Pharmacology and Experimental Therapeutics 283 3 1997 1479 1485
20. S. Mitchell, R. Ayesh, T. Barrett, and R. Smith Trimethylamine and foetor hepaticus Scandinavian Journal of Gastroenterology 34 5 1999 524 528
21. S. Mohr, H. Hallak, A. de Boitte, E.G. Lapetina, and B. Brune Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase Journal of Biological Chemistry 274 14 1999 9427 9430
22. M. Monshouwer, R.F. Witkamp, S.M. Nujmeijer, J.G. Van Amsterdam, and A.S. Van Miert Suppression of cytochrome P450- and UDP glucuronosyl transferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes Toxicology and Applied Pharmacology 137 2 1996 237 244
23. E.T. Morgan Regulation of cytochromes P450 during inflammation and infection Drug Metabolism Reviews 29 4 1997 1129 1188
24. E.T. Morgan, V. Ullrich, A. Daiber, P. Schmidt, N. Takaya, H. Shoun, J.C. McGiff, A. Oyekan, C.J. Hanke, W.B. Campbell, C.S. Park, J.S. Kang, H.G. Yi, Y.N. Cha, D. Mansuy, and J.L. Boucher Cytochromes P450 and flavin monooxygenases-targets and sources of nitric oxide Drug Metabolism and Disposition 29 11 2001 1366 1376
25. P. Muriel Regulation of nitric oxide synthesis in the liver Journal of Applied Toxicology 20 3 2000 189 195
26. C.S. Park, H.M. Baek, W.G. Chung, K.H. Lee, S.D. Ryu, and Y.N. Cha Suppression of flavin-containing monooxygenase by overproduced nitric oxide in rat liver Molecular Pharmacology 56 3 1999 507 514
27. C. Quijano, B. Alvarez, R.M. Gatti, O. Augusto, and R. Radi Pathways of peroxynitrite oxidation of thiol groups Biochemical Journal 322 Pt1 1997 167 173
28. C.A. Salkowski, G. Detore, R. McNally, N. Van Rooijen, and S.N. Vogel Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling Journal of Immunology 158 2 1997 905 912
29. M.B. Sewer, T.B. Barclay, and E.T. Morgan Down-regulation of cytochrome P450 mRNAs and proteins in mice lacking a functional NOS2 gene Molecular Pharmacology 54 2 1998 273 279
30. M.B. Sewer, and E.T. Morgan Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes Biochemical Pharmacology 54 6 1997 729 737
31. M.B. Sewer, and E.T. Morgan Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production Journal of Pharmacology and Experimental Therapeutics 287 1 1998 352 358
32. D.I. Simon, M.E. Mullins, L. Jia, B. Gaston, D.J. Singel, and J.S. Stamler Polynitrosylated proteins: characterization, bioactivity, and functional consequences Proceedings of the National Academy of Sciences of the United States of America 93 10 1996 4736 4741
33. J.S. Stamler, S. Lamas, and F.C. Fang Nitrosylation. the prototypic redox-based signaling mechanism Cell 106 6 2001 675 683
34. J.S. Stamler, D.I. Simon, J.A. Osborne, M.E. Mullins, O. Jaraki, T. Michel, D.J. Singel, and J. Loscalzo S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds Proceedings of the National Academy of Sciences of the United States of America 89 1 1992 444 448
35. M. Stefek, L. Benes, and V. Zelnik N-oxygenation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent: the role of flavin-containing monooxygenase Xenobiotica 19 2 1989 143 150
36. D.A. Wink, Y. Osawa, J.F. Darbyshire, C.R. Jones, S.C. Eshenaur, and R.W. Nims Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent Archives of Biochemistry and Biophysics 300 1 1993 115 123
37. M. Xian, X. Chen, Z. Liu, K. Wang, and P.G. Wang Inhibition of papain by S-nitrosothiols. Formation of mixed disulfides Journal of Biological Chemistry 275 27 2000 20467 20473
38. D.M. Ziegler Flavin-containing monooxygenases: catalytic mechanism and substrate specificities Drug Metabolism Reviews 19 1 1988 1 32